INO - Inovio Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INO is currently covered by 4 analysts with an average price target of $14.98. This is a potential upside of $12.9 (620.19%) from yesterday's end of day stock price of $2.08.

Inovio Pharmaceuticals's activity chart (see below) currently has 101 price targets and 107 ratings on display. The stock rating distribution of INO is 90% HOLD and 10% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.82% with an average time for these price targets to be met of 544.57 days.

Highest price target for INO is $6, Lowest price target is $3, average price target is $14.98.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 13-Jan-2025. First documented stock forecast 18-Jun-2014.

Currently out of the existing stock ratings of INO, 9 are a HOLD (90%), 1 are a BUY (10%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$3

$0.92 (44.23%)

$5

5 days ago
(13-Jan-2025)

4/7 (57.14%)

$1.1 (57.89%)

914

Hold

$6

$3.92 (188.46%)

$7

2 months 3 days ago
(15-Nov-2024)

13/18 (72.22%)

$1.75 (41.18%)

417

Buy

$4

$1.92 (92.31%)

11 months 24 days ago
(25-Jan-2024)

2/2 (100%)

$-2.79 (-41.09%)

367

Hold

$4.8

$2.72 (130.77%)

1 years 2 months 8 days ago
(10-Nov-2023)

1/1 (100%)

$0.61 (14.56%)

6

Hold

$240

2 years 2 months 9 days ago
(09-Nov-2022)

7/8 (87.5%)

$94.32 (64.74%)

713

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is INO (Inovio Pharmaceuticals) average time for price targets to be met?

On average it took 544.57 days on average for the stock forecasts to be realized with a an average price target met ratio 85.82

Which analyst has the current highest performing score on INO (Inovio Pharmaceuticals) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on INO (Inovio Pharmaceuticals)?

Charles Duncan works at CANTOR FITZGERALD and has 11 price targets and 8 ratings on INO

Which analyst is the currently most bullish on INO (Inovio Pharmaceuticals)?

Thomas Shrader with highest potential upside - $129.92

Which analyst is the currently most reserved on INO (Inovio Pharmaceuticals)?

Jason Kolbert with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?